gout of foot The investigational drug AR882 appeared more effective and safer than allopurinol monotherapy in a phase 2 trial. A novel selective URAT1 inhibitor, AR882, further reduces serum uric acid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback